A Clinical Comparative Study of Oral Aprepitant and Injection Palonosetron for Prevention of Postoperative Nausea and Vomiting in Patients of Laparoscopic Cholecystectomy under General Anaesthesia

J. Agrawal
{"title":"A Clinical Comparative Study of Oral Aprepitant and Injection Palonosetron for Prevention of Postoperative Nausea and Vomiting in Patients of Laparoscopic Cholecystectomy under General Anaesthesia","authors":"J. Agrawal","doi":"10.23880/accmj-16000143","DOIUrl":null,"url":null,"abstract":"Aim: To assess and evaluate effect of oral aprepitant and injection palonosetron for prevention of post-operative nausea vomiting [PONV] in patients posted for laparoscopic cholecystectomy under general anaesthesia. Background: Laparoscopic surgeries have been performed now a day’s very frequently. The patients undergoing laparoscopic cholecystectomy under general anaesthesia have high risk for post-operative nausea and vomiting [PONV] with incidence up to 75%. Method: 90 patients of ASA grade I and II undergoing laparoscopic cholecystectomy were registered for this study. They were divided randomly into 3groups of 30 each who received 1capsule (80 mg) aprepitant orally 3 hrs before and 2ml of normal saline IV 10 minute prior to induction in group A, or 1capsule (80 mg) aprepitant orally 3 hrs before and 2ml of normal saline IV 10 minute prior to induction in group P and placebo 1 capsule orally 3 hrs before and 2ml of normal saline intravenous (IV) 10 minute prior to induction in group C. After extubation patients were watched and monitored for nausea, retching and vomiting for 30 min., 60min, 2 hour, 6 hour, 12 hour, and 24 hour in postoperative period. Results: Palonosetron and Aprepitant both are the effective in reducing the incidence of post-operative nausea and vomiting up to 24 hours, when given prior to induction of general anaesthesia. Aprepitant is more effective than Palonosetron in reducing the nausea and vomiting in post-operative period.","PeriodicalId":313122,"journal":{"name":"Anaesthesia & Critical Care Medicine Journal","volume":"18 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anaesthesia & Critical Care Medicine Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23880/accmj-16000143","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To assess and evaluate effect of oral aprepitant and injection palonosetron for prevention of post-operative nausea vomiting [PONV] in patients posted for laparoscopic cholecystectomy under general anaesthesia. Background: Laparoscopic surgeries have been performed now a day’s very frequently. The patients undergoing laparoscopic cholecystectomy under general anaesthesia have high risk for post-operative nausea and vomiting [PONV] with incidence up to 75%. Method: 90 patients of ASA grade I and II undergoing laparoscopic cholecystectomy were registered for this study. They were divided randomly into 3groups of 30 each who received 1capsule (80 mg) aprepitant orally 3 hrs before and 2ml of normal saline IV 10 minute prior to induction in group A, or 1capsule (80 mg) aprepitant orally 3 hrs before and 2ml of normal saline IV 10 minute prior to induction in group P and placebo 1 capsule orally 3 hrs before and 2ml of normal saline intravenous (IV) 10 minute prior to induction in group C. After extubation patients were watched and monitored for nausea, retching and vomiting for 30 min., 60min, 2 hour, 6 hour, 12 hour, and 24 hour in postoperative period. Results: Palonosetron and Aprepitant both are the effective in reducing the incidence of post-operative nausea and vomiting up to 24 hours, when given prior to induction of general anaesthesia. Aprepitant is more effective than Palonosetron in reducing the nausea and vomiting in post-operative period.
口服阿瑞吡坦与注射帕洛诺司琼预防全麻腹腔镜胆囊切除术患者术后恶心呕吐的临床比较研究
目的:评价和评价口服阿瑞吡坦与注射帕洛诺司琼预防全麻腹腔镜胆囊切除术患者术后恶心呕吐的效果。背景:腹腔镜手术已成为当今世界进行的最频繁的手术。全麻下腹腔镜胆囊切除术患者术后恶心呕吐的发生率较高,可达75%。方法:90例ASA 1级和2级腹腔镜胆囊切除术患者。他们被随机分为3组,每组30人收到1胶囊(80毫克)aprepitant口服3小时前和2毫升生理盐水静脉归纳在一个组,前10分钟或1胶囊(80毫克)aprepitant口服3小时前和2毫升生理盐水静脉诱导前10分钟P和安慰剂组1胶囊口服3小时前和2毫升生理盐水静脉注射(IV) 10分钟前感应拔管后在c组患者观察和监控为恶心、术后30分钟、60分钟、2小时、6小时、12小时、24小时干呕。结果:在全麻诱导前给予帕洛诺司琼和阿瑞吡坦均能有效减少术后24小时内恶心和呕吐的发生率。阿瑞吡坦减轻术后恶心呕吐的效果优于帕洛诺司琼。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信